cjc 1295 and ipamorelin vs tesamorelin CJC-1295 with cjc-1295 ipamorelin vs tesamorelin comparison

The DAC (Drug Affinity Complex) modification binds reversibly to albumin, extending the peptides half-life to approximately 68 days [1]

Ut quis tempus libero

TB-500 legal status Current legal status: Not FDA-approved Legal to buy as research chemical Legal to possess Gray area to use Banned by WADA for athletes Similar to BPC-157: Same regulatory gray area applies

The DAC version uses a drug affinity complex that extends half-life through albumin binding

(2) Fragment 176-191 peptide, composed of 16 amino acids, including the last 15 amino acids from 177 to 191 found in hGH, has tyrosine added at the N-terminus (beginning)

Comparing These Four Peptides | Compound | Primary Target | Main Effect | |---|---|---| | Sermorelin | GHRH Receptor | Stimulates endogenous GH release | | CJC-1295 | GHRH Receptor | Sustained GH stimulation | | Ipamorelin | Ghrelin Receptor (GHS-R1a) | Triggers GH secretion | | IGF-1 LR3 | IGF-1 Receptor | Direct tissue-level IGF signaling | For a deeper dive into the specific compounds available, see our Peptide Therapy Education page, which catalogs 23 active peptide compounds with full mechanism-of-action references